In postmenopausal women, multimodal or US screening for ovarian cancer did not reduce ovarian cancer mortality
- 1 October 2021
- journal article
- editorial
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 174 (10), JC114
- https://doi.org/10.7326/acpj202110190-114
Abstract
Source Citation Menon U, Gentry-Maharaj A, Burnell M, et al. Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (U... Clinical Impact Ratings GIM/FP/GP: 6 out of 7 Public Health: 6 out of 7This publication has 3 references indexed in Scilit:
- Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk – Combined Results from Two Screening TrialsClinical Cancer Research, 2017
- Extended mortality results for ovarian cancer screening in the PLCO trial with median 15 years follow-upGynecologic Oncology, 2016
- The Preclinical Natural History of Serous Ovarian Cancer: Defining the Target for Early DetectionPLoS Medicine, 2009